Steve Albers is Corporate Vice President, Market Access and Public
Affairs for Novo Nordisk Inc. since May 2017.
Mr. Albers leads the US Market Access team in setting strategies and
providing national leadership in communicating the value of all Novo
Nordisk products to key payer customers.
Additionally, he directs the Public Affairs team on engagement with
policy makers, educating them on the significance of the disease
states that patients face as well as the business complexities that
Novo Nordisk navigates. Mr. Albers is responsible for helping ensure
that patients who need Novo Nordisk's medicines are able to get them.
Previously, Mr. Albers was Vice President of Market Access National
Accounts, where he was responsible for payer marketing, contract
strategy, pricing and account management for Novo Nordisk's portfolio
of US medicines.
Mr. Albers has more than 20 years of experience within the medical
and pharmaceutical industries. He joined Novo Nordisk in 2006 as
District Business Manager in Minnesota achieving increasing levels of
responsibility in the Sales and Market Access organization. He spent
almost five years in Novo Nordisk's global headquarters in Denmark as
Senior Global Marketing Director for Market Access before he was
appointed Vice President of Global Market Access.
Prior to joining Novo Nordisk, Mr. Albers was a regional account
manager for Serono Inc., a biotechnology company acquired by Merck.
Before that, he worked at Takeda Pharmaceuticals America in various
sales and account management roles of increasing responsibility.
He holds a bachelor's degree in biology from Concordia College in Minnesota.